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ABSTRACT 
Porcine Reproductive and Respiratory Virus (PRRSV) and Porcine Circovirus Type 2 
(PCV2) are both viruses which cause significant economic and production losses to the swine 
industry around the world. The gold standard for monitoring these viruses is real-time PCR. 
Sequencing assays are also used to keep track of the epidemiology of these viruses. The work 
presented in this thesis aims to examine the repeatability of these types of assays with various 
concentrations of virus and within common diagnostic sample types. 
The repeatability of real-time PCR assays for PRRSV and PCV2 was examined using 
clinical specimens of various sample types which were submitted to the Iowa State University 
(ISU) Veterinary Diagnostic Laboratory (VDL). This was accomplished by creating a dilution 
series for each virus and for each of the specimen types: viral isolate, lung homogenate, serum, 
and oral fluids. These samples were diluted to targeted Cq ranges of 31-32, 32-33, 33-34, 34-35, 
35-36, 36-37, 37-38, 38-39, 39-40. The dilutions were performed into negative material of the 
same sample matrix as the clinical specimen. The nucleic acids were then extracted in triplicate. 
Ten PRRSV RT-qPCR assays were performed from each extract for each sample matrix, and 15 
qPCR reactions from each for PCV2. The repeatability was then determined as a percentage of 
the positive results from each group. Repeatability was also evaluated based on the cutoff of 40 
or 37 cycles for PRRSV, and 40 or 35 cycles for PCV2.  
The repeatability of a sequencing assay for PRRSV open reading frame (ORF) 5 was also 
evaluated in this work. A similar methodology used to examine the real-time assays was used to 
evaluate the sequencing assay. The samples were diluted to different targeted Cq range of 29-30, 
30-31, 31-32, 32-33, 33-34, 34-35, 35-36, 36-37. Five amplification PCRs were performed from 
each extract. Amplification product was then sequenced via Sanger sequencing. The sequencing 
x 
data was determined to be successful or unsuccessful. The repeatability was determined as the 
number of acceptable sequences out of the total sequencing attempts that were performed. 
Acceptable sequences were also compared to each other within their expected Cq group using a 
phylogenetic analysis to evaluate the repeatability of the nucleic acids determined by the 
sequencing software. 
The work in this thesis aims to examine the repeatability of these important diagnostic 
assays as they approach the limit of detection. The research presented here shows the 
repeatability of these real time PCR assays decrease as the Cq values increase. A decrease in 
repeatability of acceptable sequences with increasing Cq values was also observed for the ORF5 
sequencing assay for PRRSV. These findings were true for each of the sample matrices 
evaluated.
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CHAPTER 1.    GENERAL INTRODUCTION 
Statement of the Problem 
Real-time PCR assays have become the gold standard for detecting many pathogens 
within the swine industry. The results of these assays have important economic consequences for 
producers. It has been anecdotally observed within diagnostic laboratories such as the ISU VDL 
that repeatability of these real-time assays, and obtaining successful nucleotide sequences, often 
decreases with higher Cq values suggesting concentration of the virus in a specimen may impact 
the ability to repeat the same result on repeated testing. The goal of the work presented here was 
to scientifically evaluate and determine the repeatability of these diagnostic assays. 
Specific Aims 
The objective of the work presented in this thesis was to evaluate and determine the 
repeatability of common diagnostic real-time PCR assays and sequencing assays within different 
sample matrices. Chapter 2 aims to determine the repeatability of real-time PCR assays for 
PRRSV and PCV2. The main hypothesis for Chapter 2 is: as the Cq values increase (target 
concentrations decrease), the repeatability of the assay decreases. Chapter 3 aims to determine 
the repeatability of a PRRSV ORF5 sequencing assay. The hypothesis for Chapter 3 is: as the Cq 
increases, the probability of repeating an acceptable sequencing reaction decreases and the 
repeatability of individual nucleic acids at specific positions in a sequence also decreases. 
Thesis Organization 
This thesis is organized based on the journal-paper format. There are four chapters to this 
thesis, two of which are being prepared for publication. Chapter 1 is an overview of the literature 
surrounding this work. Chapters 2 and 3 are manuscripts in the process of being prepared for 
publication. Chapter 2 discusses repeatability a PRRSV reverse transcription real-time PCR and 
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a PCV2 real-time PCR and is being prepared for publication in the Journal of Virological 
Methods. Chapter 3 discusses the repeatability of a PPRSV ORF5 sequencing assay and is being 
prepared for publication in the Journal of Veterinary Diagnostic Investigation. Finally, Chapter 4 
is a general conclusion to the thesis. 
Literature Review 
PRRSV and PCV2 Infections in Swine 
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) belongs to the 
Arteriviridae family that includes Equine arteritis virus and Simian hemorrhagic fever virus. 
Members of Artierividae contain a positive sense RNA genome in an enveloped capsid 
(Zimmerman et al. 2012a). The PRRSV genome is approximately 15kb in length and consists of 
positive sense RNA organized into 11 open reading frames (Conzelmann et al. , Zimmerman et 
al. 2012a). PRRSV has two major species, type 1 and type 2. Type 1 PRRSV was first isolated in 
1991 in the Netherlands (Wensvoort et al. 1991). Type 2 PRRSV was isolated later that same 
year in the United States (Collins et al. 1992). While both species are found throughout the 
world, type 1 PRRSV is commonly referred to as the European strain and type 2 is referred to as 
the North American strain. 
PRRSV is responsible for one of the costliest diseases of swine production across the 
world. Since the disease’s discovery in the late 1980’s, it has continued to have an increasingly 
negative impact on swine production. An economic study from 2005 found that the virus caused 
approximately $560 million in losses to the United States (US) swine industry (Neumann et al. 
2005). In 2012, the economic impact of the virus was estimated at $664 million per year to 
producers in the US based on data gathered from 2005-2010 (Holtkamp et al. 2013a).  
 Porcine Circovirus type 2 (PCV2) belongs to the family Circoviridae. The clinical 
disease and conditions caused by PCV2 and other porcine circoviruses are referred to as porcine 
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circovirus-associated diseases (PCVAD) (Opriessnig, Meng and Halbur 2007). Clinical disease 
is broadly described due to the ability of the virus to manifest itself in many different ways 
(Zimmerman et al. 2012a). PCV1 and 2 were first discovered in the late 1990’s, with PCV2 
discovered in 1999 (Allan et al. 1999). PCV2 is a non-enveloped, icosahedral virus which 
contains a single stranded DNA genome. The genome is circular and relatively small with a 
nucleotide length of approximately 1767bp (Zimmerman et al. 2012a), and is organized into 11 
opening reading frames (Hamel, Lin and Nayar 1998). 
 PCV2 is a costly disease to the swine industry and can be responsible for significant 
production and economic losses. In the US, PCV2 has been estimated to cost swine producers 
approximately $20 per pig (Gillespie et al. 2009a). PCV2 has continued to spread and increase in 
prevalence over the previous twenty years. Data from the United States Department of 
Agriculture (USDA) National Animal Health Monitoring System (NAHMS) shows that from 
2000 to 2012 in the US, the overall prevalence increased from 5.7% to 22.3% (USDA 2002, 
USDA 2012). Due to its economic and production impact, PCV2 has become a highly monitored 
virus in swine production systems as it continues to impact production practices with the need to 
minimize disease spread and infection (Gillespie et al. 2009a).  
Real-time Polymerase Chain Reaction 
Polymerase chain reaction (PCR) technology has advanced greatly since its introduction 
in the early 1980’s. The ability to amplify DNA sequences from small amounts of nucleic acid 
not only changed the landscape for biological research, but also in the diagnostic realm. In 1988 
it was discovered that a thermostable polymerase could be used to improve PCR (Saiki et al.). 
With a heat-stable polymerase enzyme, the cycling steps for PCR could now be combined into 
one reaction, without needing the manual addition of enzyme for each reaction. This allowed 
PCR to become less labor intensive and less time consuming. Combining reverse transcriptase 
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with PCR (RT-PCR) allowed the amplification of complementary DNA (cDNA) synthesized 
from an RNA template. This was an important advancement allowing the amplification of 
genetic material from RNA viruses. In 1993, PCR technology was further improved with the 
introduction of quantitative or real time PCR (qPCR). It was determined that the amount of PCR 
product could be monitored in real-time during the successive thermal cycling reactions using 
florescent tags (Higuchi et al. 1993).  
The development of multiplex PCR was another important variation in the evolution of 
PCR as a research and diagnostic tool. This method of PCR, first described in 1988, allows for 
the use of multiple primers in one reaction (Chamberlain et al. 1988). This allows simultaneous 
detection of multiple targets within a single sample at a lower cost than performing the assays 
individually. With the ability to detect multiple targets, diagnostic assays could become more 
complex. Real-time panel assays have also become common in molecular diagnostics. These 
panels often test a sample for multiple pathogens collected from organisms presenting similar 
clinical signs using a combination of singleplex or multiplexed assays. This shortens the time to 
a diagnosis by testing concurrently for the most common agents associated with a defined 
clinical presentation. (Cho et al. 2010). The introduction of multiplex PCR also allows the 
addition of internal controls (ICs), which have become integral to providing more accurate real-
time PCR assays due to their ability to monitor the success of a reaction when the test result is 
negative. There are two main types of ICs. The first is an IC that makes use of a housekeeping 
gene or sequence which should be present in all samples, typically within the host organism 
(endogenous IC). The second is an IC which is synthetic, containing a nucleic acid target 
sequence added during the extraction or amplification step (exogenous IC) to amplify in parallel 
with the specified target (Rosenstraus et al. 1998). Internal controls are useful to diagnostic 
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assays. They can be used to ensure that extraction of nucleic acids from a sample was successful, 
if added before the extraction process. They can also be used to determine if there was inhibition 
of amplification (Rosenstraus et al. 1998). 
Reverse transcription quantitative PCR (RT-qPCR) and qPCR have both become gold 
standards for many diagnostic tests in the medical field, both animal and human; the food safety 
field; and agricultural field. RT-qPCR and qPCR are not only used for the detection and 
diagnosis of pathogens but can also be used for the detection of genetic diseases and expression 
of oncogenes. While assays can be relatively easy to create, there are many factors to consider 
when developing a robust and accurate PCR assay. In 2009, “The MIQE Guidelines: Minimum 
Information for Publication of Quantitative Real-Time PCR Experiments” was published to help 
standardize what information is important when developing and publishing real-time PCR assays 
(Bustin et al. 2009b).   
Many of the standardized methods and terminologies proposed in the MIQE Guidelines 
were adopted and continue to be used today. For example, Bustin et al proposed the use of 
quantification cycle (Cq) as the descriptor for real-time results at the point where fluorescence 
crosses a set threshold instead of threshold cycle (Ct), crossing point (Cp), or take-off point 
(TOP)(Bustin et al. 2009b). They proposed a more simplified nomenclature for different types of 
PCR assays as well. It was proposed that real-time PCR should not be shortened to RT-PCR, as 
this was typically used for reverse-transcription PCR, and instead they recommended using 
qPCR, meaning quantitative PCR (Bustin et al. 2009b). This terminology is not always uniform 
across all publications and journals, however. In the Journal of Veterinary Diagnostic 
Investigation (JVDI), it is preferred to use rtPCR for real-time PCR and RT-rtPCR for reverse-
transcription real-time PCR. JVDI recommends using the specific term “qPCR” only when the 
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real-time PCR is performed using a standard curve to determine a true quantitative result (Maxie, 
Farrell and Uzal 2016). 
When developing real-time assays for use in a diagnostic setting, there are many 
parameters to consider which can evaluate the performance of the assay. The major features to 
consider are an assay’s sensitivity, specificity, accuracy, repeatability, and reproducibility. These 
features are important to understand when utilizing real-time diagnostic assays (Bustin et al. 
2009b). Sensitivity is often represented by the limit of detection (LOD) (Bustin et al. 2009b). 
The LOD is the lowest amount of the target that can be detected 95% of time with both technical 
and experimental replicates (Kralik and Ricchi 2017). The ability to detect low levels of a target 
nucleotide sequence is important in diagnostics. This could lead to the detection of a pathogen 
which has yet to show clinical signs (Lachaud et al. 2000). Accuracy has been defined as the 
quantitative difference between the assay’s results and the known quantity of an experimental 
sample (Bustin et al. 2009b).  
Specificity refers to how accurately the assay can detect the specific target for which the 
assay was designed (Bustin et al. 2009b). The specificity should be designed to be restrictive 
enough to eliminate the possibility of detecting unrelated targets that may be present in the 
sample, while maintaining the ability to detect all the varieties of a pathogen including 
subspecies, strains, quasispecies etc. This is referred to as exclusivity and inclusivity, 
respectively (Kralik and Ricchi 2017). If an assay detects an unrelated pathogen with a similar 
nucleotide sequence, this can yield false positive results. In diagnostics, false positives can 
greatly impact the decision making that is based on the test result, including appropriate 
treatment of a condition or pathogen, or movement of the animals being tested. When an assay is 
designed too specifically to a target, the results could give false negatives if it does not account 
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for genetic variations within the targeted area of genome. People, animals, and plants which have 
been falsely identified as negative for a pathogen have the potential to spread the pathogen or 
develop more serious clinical symptoms without early treatment. 
Reproducibility and repeatability are the last two major parameters; they can also be 
referred to as long-term precision and short-term precision, respectively (Bustin et al. 2009b). 
Reproducibility is measured by the variation observed in results when an assay is used across 
multiple laboratories or different runs (Bustin et al. 2009b). Reproducibility is important to 
consider and examine for assays that will be used by a number of different laboratories and thus, 
commercial assays should demonstrate adequate reproducibility. Repeatability is the measure of 
an assay’s ability to return the same results when the same sample is tested multiple times 
(Bustin et al. 2009b). Ideally, repeatability should be measured using the same reagents, 
equipment, personnel, and lab spaces. High repeatability is demonstrated when all these 
parameters are unchanged, and the assay returns the same result across multiple, repeated testing. 
All these parameters must be carefully evaluated and optimized in a way to maximize the 
usefulness of an assay. This is critical in the field of molecular diagnostics. Assays which are 
designed for use in research labs may lack the need to be as critical of these parameters, 
depending on the researcher’s questions or scale of the research. In diagnostic laboratories, 
samples are often received from many different sources and with unknown status. It is important 
that these assays are well-designed to account for the wide degree of variability that arises from 
field and clinical samples. 
Animal Production Diagnostics 
Real-time PCR has become the gold standard for detecting many pathogens in animal 
production. Many veterinary diagnostic laboratories (VDLs) currently offer a multitude of real-
time PCR and sequencing assays for many different pathogens and for different host species. The 
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Iowa State University (ISU) VDL offers over 100 different PCR assays for various pathogens 
and species. Due to the economic impact of pathogens in animal production, the accuracy, 
repeatability, sensitivity, and specificity of these tests are paramount. Understanding the 
advantages and more importantly, the limitations, of these assays is imperative for veterinarians, 
producers, diagnostic laboratories, and pathologists. Many production management decisions 
rely on these test results and these management decisions can cost production operations 
thousands to millions of dollars depending on the size of the operation (Gillespie et al. 2009a, 
Holtkamp et al. 2013a).  
Producers rely heavily on routine testing by VDLs to monitor animal health. Routine 
sampling and testing have become an essential part of many disease surveillance and infection 
control programs (Salman 2003, Lopez et al. 2018). Due to the integral nature of real-time PCR 
to these monitoring procedures, it is paramount these assays provide accurate and reliable results. 
Understanding the shortcomings of an assay and the factors outside of assay design which can 
influence the accuracy of the results is also essential to providing reliable diagnostic results. 
There are many factors to consider that could have an impact on the assay. Sample type is a 
major factor which affects PCR results. Different specimen types have different advantages and 
disadvantages based on diagnostic questions, ease of sample collection, time of collection, and 
level and type of PCR inhibitors present in the matrix (Chittick et al. 2011, Kittawornrat et al. 
2014). 
Decisions based on real-time PCR results often have an economic impact on the 
producer. In the case of PRRSV, receiving an unexpected positive result could be very costly. 
Many management decisions need to be made based on a positive result such as the decision to 
begin a PRRSV control or elimination program (Corzo et al. 2010). A possible method producers 
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can employ to eliminate a PRRSV outbreak is to depopulate and repopulate an infected herd 
(Corzo et al. 2010). This method is highly effective at eliminating PRRSV from a site, but it is 
very costly to the producers. Before a method such as depopulation is used, clients often request 
a retest of unexpected positive PCR results to confirm the original outcome. The majority of 
retests will confirm the original result and the producer will take the appropriate actions needed 
to control or eliminate the virus from the operation. However, in some situations, the original 
real-time PCR result will have a high or elevated Cq value close to the cut-off of the assay. These 
Cq values correlate to a low level of nucleic acid present in the sample and ultimately, the qPCR 
reaction. In these cases of elevated Cq values, the retest may not always repeat positive due to the 
low quantity of nucleic acid present. This has been experienced at the ISU VDL and a 
discrepancy between the original result and the retest result can cause confusion for the clients 
and veterinarians trying to interpret the results. These nonrepeating events could be interpreted 
by the clients as an error in the analysis, cross contamination, or sample mishandling, when in 
fact these events appear to be a limitation of the assay. In cases of nonrepeating results, more 
diagnostic tools must be used to determine the true status of the population.  
Along with real-time PCR assays, sequencing assays are also an essential part of PRRSV 
monitoring and management (Murtaugh 2012). Tracking different strains of PRRSV has been 
common since the mid 1990’s. Initially, this was achieved through the use of restriction fragment 
length polymorphism (RFLP) patterns of the PRRSV open reading frame 5 (ORF5) (Murtaugh 
2012). RFLP was useful for differentiation between vaccine and wild type strains of PRRSV. It 
was eventually found that RFLP was not the most accurate measurement of sequence similarity 
or relatedness. Often, PRRSV with the same RFLP patterns were determined to be genetically 
different (Murtaugh 2012). Sequencing the PRRSV open reading frame 5 (ORF5) via Sanger 
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sequencing is much more accurate than RFLP patterns, and sequencing is still commonly used 
today to monitor PRRSV epidemiology (Murtaugh 2012). VDLs commonly offer sequencing 
assays to clients. Sequencing assays are often a follow up to a positive real-time PCR result. 
Similar to real-time PCR, sequencing amplification reactions may not always repeat at elevated 
Cq values or low concentrations of a pathogen in a sample may result in poor quality sequences. 
Sequencing also has an additional repeatability parameter to evaluate: the nucleic acid sequences 
after the amplification reaction. Ensuring that the nucleic acid sequence is repeatable is important 
to clients. Clients will often utilize sequences for phylogenetic analysis of PRRSV strains in their 
production operations (Murtaugh 2012). 
The work presented in this thesis aims to demonstrate the effect of high Cq values on the 
repeatability of real-time PCR and sequencing assays, while also evaluating high Cq values in 
different swine sample matrices that are commonly submitted to the ISU VDL. Understanding 
the frequency at which these non-repeating events occur is critical to diagnosticians, diagnostic 
laboratories, pathologists, and veterinarians. The information and research presented here is 
essential to providing thorough, accurate, and reliable diagnostic results. 
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Abstract  
Repeatability of real-time polymerase chain reaction (rtPCR) cycle quantification (Cq) 
values depends on multiple factors including the concentration of the target in the specimen.  The 
repeatability of a reverse transcription rtPCR (RT-rtPCR) assay for porcine reproductive and 
respiratory syndrome virus (PRRSV) and rtPCR for porcine circovirus type 2d (PCV2) were 
evaluated using virus isolates and positive clinical specimens submitted to the Iowa State 
University Veterinary Diagnostic Laboratory (ISU VDL). The virus isolate and PCR positive 
lung homogenate, serum, and oral fluid were diluted to expected Cq values within the ranges of 
31-32, 32-33, 33-34, 34-35, 35-36, 36-37, 37-38, 38-39, 39-40. Nucleic acids were extracted in 
triplicate from each expected Cq range and 10 PRRSV and 15 PCV2 PCR reactions were 
performed on each extract to evaluate the repeatability of actual Cq values and positive results 
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based on different Cq cutoffs at each expected Cq range. The results demonstrated a decrease in 
repeatability and significant increase in the variance of actual Cq values between expected Cq 
ranges as concentrations of the target decreased in the specimen for PRRSV and PCV2. 
Repeatability of positive actual Cq values also decreased at target concentrations near the cutoff 
regardless of the virus or sample matrix. 
Introduction 
Reverse transcription real-time PCR (RT-rtPCR) and real-time PCR (rtPCR) are 
commonly used in veterinary diagnostic laboratories to detect pathogenic viruses and bacteria. 
Since the inception of PCR in 1985, the efficiency, sensitivity and specificity have improved. In 
addition, these tests have become simplified, rapid and can support high throughput workflows 
that are indispensable to animal production that requires timely and accurate results to 
adequately implement management and health decisions(Sayler et al. 2017). A PCR assay must 
demonstrate high analytical and diagnostic sensitivity and specificity as well as intraassay 
repeatability and interassay reproducibility to reduce potential false positive and negative results 
(Bustin and Wittwer 2017). Guidelines have been established for creating new PCR assays or 
evaluating existing assays to evaluate whether these criteria have been sufficiently implemented 
or evaluated(Bustin and Wittwer 2017). However, extrinsic factors beyond assay design may 
affect the sensitivity, specificity, reproducibility and repeatability of PCR detection of viral RNA 
or DNA. These may include stage of the disease process in an animal or population, specimen 
handling, specimen storage, and shipping conditions as well as specimen type and 
quality(Granados et al. 2017, Zimmerman et al. 2012b). Many of these factors may affect the 
concentration of the target in a specimen through degradation of nucleic acid or the stage of 
disease process at the time of sample collection may influence the quantity of target present in a 
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clinical specimen(Granados et al. 2017, Jerome et al. 2002, Jose et al. 2003, Jose, Gajardo and 
Jorquera 2005, Weiser et al. 2018). 
Porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus 
type 2 (PCV2) are the cause of respiratory and systemic disease in swine with substantial 
economic losses(Gillespie et al. 2009b, Holtkamp et al. 2013b). Complex monitoring and 
surveillance programs are necessary to help control the transmission of these viruses in swine 
production systems(Lopez et al. 2018, Salman 2003). Diagnostic tests that includes RT-rtPCR 
and rtPCR are used to detect viral RNA or DNA, respectively, in clinical specimens for 
monitoring and surveillance systems(Dee et al. 2001). Utilizing sensitive diagnostic assays such 
as PCR are particularly useful when detecting small concentrations of virus in specimens 
collected from swine populations with low prevalence of infection(Kittawornrat et al. 2014). In 
addition, sensitive, specific and repeatable diagnostic tests such as PCR are necessary to 
adequately monitor the detection of viruses and other pathogens to prevent inaccurate results that 
could impact production and cause significant economic consequences to the producer and 
animal agriculture. 
In spite of their high analytical sensitivity, the repeatability of RT-rtPCR or rtPCR cycle 
quantification (Cq) values may be influenced by the concentration of viral RNA or DNA in the 
specimen or precision of Cq values may become more variable with repeated testing as target 
concentrations approach the assay’s limit of detection(Bustin et al. 2009a). This phenomenon is 
common in veterinary diagnostic laboratories where specimens are submitted from field cases 
that lack clinical information including history, expected prevalence of the target, or stage of the 
disease process that may affect target concentration in the specimen. Unexpected results at or 
near the cutoff Cq are reported positive, but are considered weak, of questionable significance, 
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and often require a retest that may or may not repeat the original positive result or similar Cq 
value. These outcomes often cause confusion for individuals interpreting test results and a lack 
of confidence in the test results. The lack of repeatability may be interpreted as cross 
contamination that occurred at the laboratory, when in fact the specimen is truly positive. 
Understanding these nonrepeating events is paramount to assuring producers, veterinarians, and 
diagnosticians that they are receiving accurate PCR results. 
The objective of this study was to evaluate the repeatability of a commercial PRRSV RT-
rtPCR and an in-house developed PCV2 rtPCR assay upon retesting using a virus isolate and 
various sample matrices of expected Cq concentrations that simulate similar conditions that are 
relevant to veterinary diagnostic laboratories. 
Materials and Methods 
Virus Isolates 
A PRRSV (PRRSV/Ohio/67318/2016) isolate with restriction fragment length 
polymorphism (RFLP) pattern 1-7-4 was isolated from serum submitted to the Iowa State 
University Veterinary Diagnostic Laboratory (ISU VDL) in 2016 and collected from adult swine 
in Ohio with an unknown history. The PRRSV 1-7-4 is 15,110 nucleotides and is a lineage 1 
virus propagated on MARC145 cells for 2 passages (GenBank number MT376723). 
A PCV2 (PCV2d/North_Carolina/24897/2016) isolate with RFLP 3-2-1 was isolated 
from the lung of a nine-week-old nursery pig submitted to the ISU VDL in 2016 with clinical 
respiratory disease and microscopic lesions consistent with PCV2-associated systemic disease. 
The PCV2d was isolated on PK-15 cells at passage 6 and is 1,767 nucleotides (GenBank 
MT376724). 
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Clinical Sample Collection and Processing 
Clinical samples selected from routine diagnostic submissions to the ISU VDL included 
lung, serum and oral fluid that were positive for PRRSV or PCV2 by RT-rtPCR or rtPCR, 
respectively that was conducted at the ISU VDL per standard operating procedures. Lung 
homogenates were prepared with 3 grams of tissue in 27mL of Earle’s Balanced Salt Solution 
(ThermoFisher Scientific, Waltham, MA) and placed in a stomacher (Thomas Scientific, 
Swedesboro, NJ) for 120 seconds. The homogenates were centrifuged for 10 minutes at 4200 x g 
at 4°C and the supernatant decanted into 5mL polystyrene tubes. Blood samples received in 
serum separator tubes by the submitting veterinarian were processed via centrifugation at 1300 x 
g for 10 minutes and the serum stored in 5mL polystyrene tubes (BD Falcon, BD Biosciences, 
San Jose, CA). Oral fluids submitted to the ISU VDL were aliquoted and stored in 5mL 
polystyrene tubes. Lung homogenates, sera and oral fluids were stored at -80°C until further use. 
Lung, serum and oral fluid submitted to the ISU VDL and RT-rtPCR or rtPCR negative for 
PRRSV and PCV2, respectively, were selected for diluting the PRRSV and PCV2 positive 
clinical samples to expected Cq values. Diluent specimens were confirmed PCR negative by 
testing in triplicate and were stored at -80°C until further use. 
Experimental Design 
The PRRSV and PCV2 virus isolates and positive clinical specimens (lung homogenates, 
sera, oral fluids) were tested via RT-rtPCR or rtPCR to establish Cq values of the stock virus 
isolate and clinical specimens. Virus isolates (PRRSV, PCV2) were diluted in phosphate 
buffered saline (PBS, 1X, pH 7.2) (ThermoFisher) and clinical specimens were diluted in their 
respective RT- or rtPCR negative lung homogenate, serum, or oral fluid matrices to an expected 
Cq range of 31-32. Subsequent 2-fold serial dilutions were created from this Cq range using PBS 
for the virus isolates or corresponding RT- or rtPCR negative diluent lung homogenate, serum, or 
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oral fluid for clinical specimens to create eight additional dilutions at expected Cq ranges 32-33, 
33-34, 34-35, 35-36, 36-37, 37-38, 38-39, and 39-40. The virus isolates and clinical specimens 
corresponding to their expected Cq range were extracted in triplicate and each extract tested 10 or 
15 times using the ISU VDL PRRSV RT-rtPCR or PCV2 rtPCR, respectively (Table 1). 
Virus Isolation 
PRRSV Virus Isolation 
The PRRSV 1-7-4 was propagated in Marc-145 cells, a clone of the African monkey 
kidney cell line MA-104(Kim et al. 1993). The cells were cultured and maintained in RPMI-
1640 medium (ThermoFisher) supplemented with 10% fetal bovine serum (Atlas Biologics, Fort 
Collins, CO), 2mM L-glutamine, 0.05 mg/mL gentamicin, 10 units/mL penicillin, 10 µg/mL 
streptomycin, and 0.25 µg/mL amphotericin B (Sigma-Aldrich, St. Louis, MO). Cells were 
grown at 37°C in 5% CO2 until confluent. 
PCV2 Virus Isolation 
The PCV2d was propagated in PK-15 cells grown in Minimum essential medium 
(ThermoFisher) with 10% fetal bovine serum (Atlas Biologics), 2mM L-glutamine, 0.05 mg/mL 
gentamicin, 10 units/mL penicillin, 10 µg/mL streptomycin, and 0.25 µg/mL amphotericin B 
(Sigma-Aldrich). Cells were incubated in 5% CO2 at 37°C until confluent. Twenty-four hours 
after inoculation, 1mL of 300mM D-glucosamine was added to the 25cm2 flask for15-20 
minutes. The D-glucosamine solution was removed, fresh MEM medium was added, and the 
cells were incubated for an additional 5-6 days. 
PRRSV and PCV2 RT-rtPCR and rtPCR 
Nucleic acids were extracted from expected Cq ranges described in Table 1 that were 
generated from the isolates, lung homogenates, sera and oral fluids using a KingFisher® Flex 
(ThermoFisher) automated magnetic particle processor system and a commercial extraction kit 
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MagMAX™ Pathogen RNA/DNA Kit (ThermoFisher) according to the manufacture’s 
specifications. Viral isolates, lung homogenates and sera were extracted using “standard” 
chemistry, whereas the oral fluids were extracted using the “high volume” chemistry. The 
“standard” lysis for the PRRSV extraction contained: 50µL of sample, 65µL of lysis/binding 
solution concentrate, 65µL of 100% isopropanol, 1µL of carrier RNA (1 µg/µL), and 2µL of 
Xeno™ RNA (10,000 copies/µL). The standard wash steps used 150µL of wash buffer 1 and 
wash buffer 2. The “standard” lysis for the PCV2 extraction contained: 50µL of sample, 65µL of 
lysis/binding solution concentrate, 65µL of 100% isopropanol, 1µL of carrier RNA (1 µg/µL), 
and 0.5µL of XIPC RNA (100,000 copies/µL)(Schroeder et al. 2012). The “high volume” lysis 
for PRRSV extraction from oral fluids contained: 100µL of sample, 120µL of lysis/binding 
solution concentrate, 120µL of 100% isopropanol, 2µL of carrier RNA (1 µg/µL) and 2µL of 
Xeno™ RNA (10,000 copies/µL).  The high-volume wash steps used 300µL of wash buffer 1 
and 450µL of wash buffer 2. The “high volume” lysis for the PCV2 extraction from oral fluids 
contained: 100µL of sample, 120µL of lysis/binding solution concentrate, 120µL of 100% 
isopropanol, 2µL of carrier RNA (1 µg/µL), and 0.5µL of XIPC RNA (100,000 copies/µL). 
Virus isolates and clinical specimens were extracted in triplicate in a 96-well format. Nucleic 
acid extracts were not frozen prior to PCR set up to eliminate possible effects from freeze/thaw 
cycles. Extracted nucleic acids were stored at 4°C and immediately used in their respective RT-
rtPCR or rtPCR reactions. 
PRRSV RT-rtPCR 
The PRRSV RT-rtPCR was performed using the 10X PRRSV Primer Probe Mix V2 from 
the VetMAX™ PRRSV NA and EU kit (ThermoFisher). The assay was modified from the 
original kit to use TaqMan Fast Virus 1-Step Master Mix (4X) with the addition of Amplitaq 360 
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DNA Polymerase. Each reaction consisted of 6.5µL of TaqMan Fast Virus 1-Step Master Mix 
(4X), 0.8µL Amplitaq 360 DNA Polymerase (5U/µL), 2.7µL of nuclease-free water, 2.0µL of 
the 10X PRRSV Primer Probe Mix V2, and 8.0µL of nucleic acid template. Each plate included 
one of each positive extraction control, positive amplification control, negative extraction 
control, and negative amplification control. The assay was conducted on the ABI-7500 Fast 
system (ThermoFisher), using the 7500 Fast System SDS Software Version 1.4.0.27. The ABI-
7500 was set to run in fast mode, with cycling conditions: 5 minutes at 50°C; 20 seconds at 
95°C; 40 cycles of 95°C for 3 seconds and 60°C for 30 seconds. The run data was analyzed with 
“auto-baseline” and a threshold of 0.1. 
PCV2 rtPCR 
PCV2 rtPCR was performed using a TaqMan Fast 1-Step assay. The assay was based on 
a modification of the rtPCR described by Opriessnig et al.(Opriessnig et al. 2003). The primer 
and probe nucleotide sequences were unchanged from Opriessnig et al, but the probe was 
modified to include a ZEN™ internal quencher (Integrated DNA Technologies, Coralville, IA) 
and the 3’ TAMRA quencher was replaced with 3' Iowa Black® FQ (Integrated DNA 
Technologies). The assay was conducted on the ABI-7500 Fast system. Each reaction contained 
5µL of TaqMan Fast Virus 1-Step Master Mix, 9.705µL of nuclease free water, 0.08µL of PCV2 
forward primer at 100µM, 0.08µL of PCV2 reverse primer at 100µM, 0.04µL of PCV2 probe at 
100µM. The assay was run on the ABI-7500 Fast system, using the 7500 Fast System SDS 
Software Version 1.4.0.27. The ABI-7500 was run in fast mode, with cycling conditions: 5 
minutes at 50°C; 20 seconds at 95°C; 40 cycles of 95°C for 3 seconds and 60°C for 30 seconds. 
The run data was analyzed with “auto-baseline” and a threshold of 0.1. 
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Data Analysis 
Data was analyzed in SAS (SAS Institute, Cary, NC) and Microsoft Excel. Actual Cq 
value variance data was evaluated using a Brown-Forsythe test for equal variance using the GLM 
Procedure in SAS. A p-value of < 0.05 was used to test for significance. Percent repeatability 
was analyzed in Microsoft Excel. 
Results 
Repeatability of PRRSV RT-rtPCR Actual Cq Values 
PRRSV RT-rtPCR was conducted on 30 extracts generated from 3 separate extractions 
for each expected Cq range to evaluate the repeatability of the actual Cq value (Table 1). 
Regardless of the sample matrix, 100% (30/30) of the actual Cq values were never within the 
expected range except for expected Cq 32-33 for the PRRSV isolate. At least 80% of the actual 
Cq values were detected within the expected Cq ranges from 31 to 34 for the isolate, lung 
homogenate and serum and at least 75% of the actual Cq values were within the expected range 
31 to 33 for the oral fluid. The percent actual Cq values decreased below 50% at the expected 
range 36-37 for the isolate and serum and below 60% for the lung homogenate and oral fluid. 
Less than 25% of the actual Cq values were detected within the expected ranges starting at 37-38 
for the isolate, lung homogenate and oral fluid and 38-39 for the serum. 
The variance was calculated for each expected Cq range to evaluate differences in the 
dispersion of the actual Cq values between contiguous expected Cq ranges for the isolate, lung 
homogenate, serum and oral fluid. Significant differences (P < 0.0001) in the variance of the 
actual Cq values within a specimen were detected between contiguous expected Cq ranges from 
31-32 through 35-36 for the lung homogenate and 31-32 through 36-37 for the PRRSV isolate, 
serum and oral fluid. Significant differences (P < 0.05) were also observed between contiguous 
expected Cq ranges from 36-37 through 39-40 for the PRRSV isolate and serum, from 36-37 
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through 38-39 for the oral fluid, and 35-36 to 36-37 and 37-38 to 38-39 for the lung homogenate. 
Collectively, these data suggest as the concentration of PCR target in the sample decreased there 
is a corresponding decrease in repeatability of the actual Cq value and increased amount of 
variance of the actual Cq values at each expected Cq range. PRRSV RT-rtPCR actual Cq values 
and their corresponding expected Cq ranges for the PRRSV isolate, lung homogenate, serum and 
oral fluid are demonstrated in Figure 1. 
Repeatability of PCV2 rtPCR Actual Cq Values 
PCV2 rtPCR was conducted on 45 extracts generated from 3 separate extractions for each 
expected Cq range to evaluate the repeatability of the actual rtPCR Cq value (Table 1). Several 
PCV2 rtPCR actual Cq values were detected above or below their corresponding expected Cq 
ranges regardless of the sample matrix or concentration of the target. Less than 75% of the actual 
Cq values were detected within their expected Cq range starting at 32-33 for the PCV2 isolate and 
33-34 for the lung homogenate, serum, and oral fluid. However, fewer than 50% of the actual Cq 
values were detected for the PCV2 isolate and serum at the expected Cq range of 34-35 and the 
lung homogenate and oral fluid at the expected Cq range of 35-36. In contrast, none of the actual 
Cq values were detected within the expected Cq range of 37-38 or higher for the PCV2 isolate 
and actual Cq values were undetected within the expected Cq range at 38-39 and higher for the 
lung homogenate, serum and oral fluid. 
Similar to the PRRSV RT-rtPCR data, decreasing concentrations of the PCV2 target 
corresponded with an increase in the variance of the actual Cq values within their corresponding 
ranges although variability appeared more extensive for the PCV2 rtPCR. Significant differences 
(P < 0.0001) in the variance of actual Cq values was observed for the PCV2 isolate, lung 
homogenate, serum, and oral fluid between contiguous expected Cq ranges 31-32 through 33-34. 
In addition, significant differences were also observed for the PCV2 isolate, lung homogenate 
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and oral fluid between contiguous expected Cq ranges from 33-34 through 34-35. Significant 
differences (P < 0.05) were also detected for the serum between contiguous expected Cq ranges 
33-34 through 36-37 and the PCV2 isolate, lung homogenate, and oral fluid between contiguous 
expected Cq ranges 34-35 through 37-38. In fact, significant differences in the variance of the 
actual Cq values were detected between all the contiguous expected Cq ranges for the oral fluid 
sample. The PCV2 rtPCR increase in magnitude of variance of the actual Cq values were aligned 
with the PRRSV RT-rtPCR actual Cq value variance and indicates a decrease in virus 
concentration corresponds with a decrease in repeatability of the actual Cq value and increase in 
variance within the expected Cq range. PCV2 rtPCR actual Cq values and their corresponding 
expected Cq ranges for the PCV2 isolate, lung homogenate, serum, and oral fluid are 
demonstrated in Figure 2. 
Repeatability of PRRSV RT-rtPCR Positive Results 
The repeatability of the PRRSV RT-rtPCR actual Cq values were categorized as positive 
or negative based on different Cq cutoff values. Designating a positive cutoff Cq of 37 for the 
PRRSV RT-rtPCR assay used at the ISU VDL, 100% (30/30) of the actual Cq values detected in 
the expected ranges from 31-32 through 35-36 were positive for the PRRSV isolate and serum 
and > 90% (27/30) were positive for the lung homogenate and oral fluid. However, only 50% 
(15/30) and 46.7% (14/30) were RT-rtPCR positive at the 36-37 expected Cq range for the 
PRRSV isolate and serum, respectively. Less than 10% (3/30) of the PRRSV isolate, lung 
homogenate, serum, and oral fluid actual Cq values were RT-rtPCR positive at and above the 
expected Cq range of 38-39. The PRRSV RT-rtPCR percent positive Cq values for the isolate, 
lung homogenate, serum and oral fluid are demonstrated in figure 3. 
When the cutoff was increased to 40, 100% (30/30) of the actual Cq values were positive 
for the lung homogenate, serum, and oral fluid at expected ranges from 31-32 through 36-37 
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whereas the PRRSV isolate demonstrated 86.7% (25/30) positive at expected Cq 36-37. At the 
expected Cq range 37-38 and higher, RT-rtPCR positive Cq values ranged from 63.3% - 86.7% 
for all specimen types and were below 63.3% (19/30) at and above expected Cq ranges 38-39. 
The PRRSV RT-rtPCR percent positive Cq values for the isolate, lung homogenate, serum and 
oral fluid are demonstrated in figure 3. 
Repeatability of PCV2 rtPCR Positive Results 
The repeatability of the PCV2 rtPCR actual Cq values were categorized positive or 
negative based on different Cq cutoff values. At a cutoff of 35, 100% (45/45) of the actual Cq 
values were positive at the expected ranges from 31-32 through 32-33 for the PCV2 isolate, lung 
homogenate, and serum in contrast to the expected Cq ranges from 31-32 through 33-34 that 
were 100% positive for the oral fluid. Only 55.6% (25/45) of the actual Cq values were rt-PCR 
positive for the PCV2 isolate at the expected Cq range of 34-35 in contrast to the lung 
homogenate (75.6%; 34/45), serum (62.2%; 28/45), and oral fluid (95.6%; 43/45). The oral fluid 
had at least 1 rtPCR positive sample with an actual Cq below 35 at the expected range 38-39 
whereas the PCV2 isolate and lung homogenate were no longer detected after the expected range 
of 36-37 and after the expected range 37-38 for serum. The PCV2 rtPCR percent positive Cq 
values for the isolate, lung homogenate, serum and oral fluid are demonstrated in figure 4. 
Using 40 as the Cq cutoff, the isolate and lung homogenate were 100% (45/45) positive 
up to the expected Cq range 33-34 and actual Cq values detected in oral fluid were 100% (45/45) 
positive up to the expected Cq range 34-35. Serum demonstrated similar results to the values 
representing a cutoff at 35 Cq. The percent actual Cq values considered positive at the 40 cutoff 
steadily decreased from the expected Cq values of 34-35 or higher and < 15% (7/45) remained 
rtPCR positive at the expected Cq range 39-40 for all specimen types. The PCV2 rtPCR percent 
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positive Cq values for the isolate, lung homogenate, serum and oral fluid are demonstrated in 
figure 4. 
Discussion 
This study evaluated the intraassay repeatability of a commercial RT-rtPCR and 
internally developed rtPCR assay conducted at the ISU VDL for two common RNA and DNA 
viruses in swine, PRRSV and PCV2, respectively. The assays were evaluated using virus isolates 
and various PCR positive specimen matrices with the intent to analyze the PCR results under 
diagnostic conditions with clinical samples. Collectively, these results demonstrated that as the 
concentration of the PCR target decreased in the PRRSV/PCV2 isolate or clinical specimens 
there was a decreasing trend in the repeatability of actual RT-rtPCR or rtPCR Cq values upon 
repeated testing of the same extract and significant increases in the variance of the actual Cq 
values for each of the expected Cq ranges. In addition, these results indicated the repeatability of 
detecting a positive RT-rtPCR or rtPCR result decreased when expected Cq values are at, or close 
to, the established cutoff of the PRRSV and PCV2 PCR assay. Similar trends were demonstrated 
in the actual Cq values across different concentrations of the target present in the virus isolate and 
the various specimen matrices although the effect of sample type could not be statistically 
compared due to the presence of genetically different strains of PRRSV or PCV2 in the samples. 
Veterinarians rely on the use of rtPCR for routine monitoring in swine production 
systems to detect the presence of a pathogen prior to pig movement or prior to potential exposure 
that may occur among swine to reduce the potential transmission of a virus that may cause 
devastating economic consequences due to production losses (Holtkamp et al. 2013b). Therefore, 
it is important to understand the limitations of rtPCR that may impact results and ultimately the 
consequences associated with their interpretation based on Cq values. Pathogen monitoring and 
surveillance in swine populations using rtPCR has become increasingly more common and 
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occurs as a monthly process, or prior to animal movement or sale to monitor the disease status of 
a population. However, routine sample collection occurs independent of the stage of the disease 
process (acute or convalescent) as the infection status of the population may be presumed 
negative but in reality, is always unknown. Routine monitoring and surveillance rtPCR positive 
results may demonstrate Cq values at or close to the cutoff that may suggest recent or subclinical 
infection but is often assumed by the submitter to represent a false positive when negative results 
were expected. Regardless, veterinarians may question the authenticity of late Cq values near the 
assay cutoff and request a retest to confirm the result prior to initiating expensive and laborious 
production procedures, halting movement of swine, or implementing virus elimination 
protocols(Rowland and Morrison 2012). However, the consequences of an assumed false 
positive result that retests negative because of poor repeatability and the subsequent transmission 
of the undetected virus in a swine population could have devastating consequences as well. The 
data in the current study suggests retesting Cq values at or near the cut-off of 37 for PRRSV and 
35 for PCV2 may result in variable repeatability depending on the sample type and/or rtPCR test. 
This information is necessary and vital for veterinarians who are responsible for decisions that 
could impact the health and economic outcomes of a swine production system. Retesting an 
elevated Cq that does not repeat may create a false sense of confidence that infection is lacking in 
a population which is truly positive. Although this phenomenon is difficult to avoid when 
diagnostic labs test only one replicate of a sample, retests conducted in triplicate may improve 
the opportunity to detect a positive specimen but increases the cost of diagnostic testing. 
The objective of this study was to evaluate two rtPCR assays under diagnostic rather than 
experimental conditions to attempt to simulate testing outcomes expected from clinical samples 
submitted to a veterinary diagnostic laboratory. Therefore, contemporary virus isolates of 
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PRRSV and PCV2 diluted in PBS were selected to represent rtPCR results without the effect of 
specimen type. In addition, PRRSV RT-rtPCR and PCV2 rtPCR positive lung homogenate, 
serum and oral fluid were selected from specimens submitted to the ISU VDL to evaluate the 
effect of sample matrix. Expected concentrations of the virus were created for the analysis based 
on the original rtPCR Cq value and two-fold dilutions of the virus or specimen to expected Cq 
ranges using the same rtPCR negative specimen matrix to eliminate effects of an alternative 
diluent and reduce potential bias that may occur when specimens are spiked with virus. Choosing 
to conduct the analysis under these conditions precluded statistical comparisons between 
specimen matrices although trends observed in these data would be similar to results expected 
from testing clinical samples and suggest sample type did not greatly impact the repeatability of 
either rtPCR assay. However, not all specimen types or variations in specimen quality that may 
affect PCR repeatability were included in the current study limiting interpretation of the results 
exclusive to what may be expected from the ISU VDL PRRSV and PCV2 PCR assays(Chittick 
et al. 2011, Huggett et al. 2008). 
The ability to detect viral RNA or DNA with rtPCR is impacted by multiple factors that 
go beyond the concentration of the target, specimen matrix, or sample quality. These may 
include sample stability, exposure to freeze-thaw cycles, sample shipping and storage conditions, 
and factors intrinsic to the rtPCR assay. In the current study, freeze-thaw cycles were not 
evaluated although retesting requests at diagnostic laboratories often occur after the specimen 
has been frozen at -80°C to preserve nucleic acid stability. However, freeze-thaw cycles have 
demonstrated negative effects on influenza A virus RNA detection although multiple freeze-thaw 
cycles are typically necessary to create an impact(Granados et al. 2017). Regardless, the effect of 
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freezing and thawing samples or their extracts was not evaluated in the current study but should 
be considered one of many factors that could affect repeatability of PCR Cq values. 
Intrinsic factors of the rtPCR assay that may also affect repeatability of Cq values 
includes differences in PCR chemistry and complementarity of the primer/probe to the target. 
The current study took advantage of specimen submissions to the ISU VDL to evaluate 
repeatability. Due to the objective to evaluate repeatability under diagnostic conditions, PCR 
efficiency was considered adequate and primer/probe mismatches, if present, were considered a 
potential consequence of field cases that are submitted to a veterinary diagnostic laboratory when 
there is no knowledge of the virus status or nucleotide sequence of the potential target. 
Regardless, the PRRSV RT-rtPCR is a commercial assay with proprietary primers and probes 
and evaluating complementarity with the virus used in this study was not possible. However, the 
whole genome sequence of the PCV2d isolate used in the current study demonstrated the ORF1 
target completely matched the forward and reverse primer and the probe in spite of repeatability 
of the PCV2 rtPCR assay trending less optimal compared to the PRRSV RT-rtPCR. Although 
the commercial PRRSV RT-rtPCR assay represented in this study is proprietary, there are at 
least 10 known primer and probe combinations included in the assay to represent the broad 
PRRSV genetic diversity circulating in swine in contrast to one primer/probe set that was 
included in the PCV2 rtPCR. The differences in number of primers and probes represented in the 
PRRSV and PCV2 rtPCR assays may have had a measurable impact on the repeatability of the 
assay and this impact should be evaluated further. 
Analytical sensitivity is the minimum number of copies in a sample that is accurately 
detected by a PCR assay and is often expressed as the limit of detection (LOD)(Bustin et al. 
2009a). The LOD is defined as the lowest concentration of a target at which 95% of the positive 
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specimens are detected(Bustin et al. 2009a). Based on this definition, Cq cutoff values would be 
influenced by the LOD of the assay, which could also affect repeatability. The rtPCR assays used 
in this study have established LODs although current Cq cutoff values using these data did not 
detect 95% of the positive specimens except the oral fluid specimen that detected 95.6% (43/45) 
positive at the 34-35 expected Cq, which is the cutoff of the assay. Our data would also suggest 
that current Cq cutoff values for each assay should be lowered by 1 Cq to improve repeatability. 
Unfortunately, lowering Cq cutoff values has the consequence of increasing the number of false 
negative results and would assume the same consequence of transmitting a virus from an infected 
animal that tested falsely negative by rtPCR. Analyzing the current rtPCR results using a cutoff 
Cq of 40, the cycle limit of the assay, would improve the level of detection, but lowers 
repeatability at the elevated Cq values increasing the possibility of negative retests and confusion 
regarding the interpretation of results and establishing a true infection status of the population. 
Unfortunately, these inherent complexities of highly sensitive PCR assays cannot be avoided and 
establishing cutoff Cq values that balance false positive and false negative detection is difficult 
and a constant challenge. 
The objective of the current study was to evaluate repeatability of rtPCR assays using 
expected Cq values that included the cutoff of the test. The expected Cq ranges described in Table 
1 were created using two-fold dilutions of a known Cq of the stock virus or specimen although 
the concentrations of the target in the subsequent dilutions would be theoretical. Although 
dilutions of the target were created using the same rtPCR negative sample matrix, serial dilutions 
may inherently increase variability in the concentration of the target. However, to increase the 
number of test replicates but reduce bias that could be introduced due to multiple dilutions, we 
chose to extract one dilution 3 times and test the approximate 90 µL from each extraction until 
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the volume was exhausted.  In addition, the triplicate extractions were performed on the same 
plate and rtPCR extractions, 30 PRRSV and 45 PCV2, were performed on the same PCR plate 
when possible to avoid additional variation in PCR outcomes and positive controls included with 
each test were evaluated for acceptable Cq values within defined ranges monitored through 
statistical process control charting. These methods were incorporated to reduce extraneous data 
variability that may occur between extractions or PCR plates/runs. In addition, the expected Cq 
ranges chosen for evaluation spanned only 1 Cq value creating rigorous expectations and 
stringent limitations on the repeatability of the rtPCR assays. However, these parameters were 
necessary to adequately evaluate the precision of the assays considering only 1 Cq value could be 
the difference between positive or negative outcomes based on the ability of the assay to 
consistently repeat Cq values and positive or negative results. Large dilutions and broader 
expected Cq ranges would have falsely improved repeatability of the assays and created 
unrealistic expectations upon retesting, particularly when Cq values are close to the cutoff or 
within the range of the LOD of the assay. 
Real-time PCR has become an indispensable tool in diagnostics over the past decade. 
This study has created important information for producers, veterinarians, pathologists, 
diagnosticians, and diagnostic labs. The data and results presented here can help improve the 
understanding, usefulness, and limitations of these powerful diagnostic tools. Better 
understanding the applications and limitations of real-time diagnostic PCRs will provide great 
benefit to diagnostic labs, researchers, and producers. 
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Figures and Tables 
Table 2.1 Experimental design describing the expected Cq range values, number of extractions 
per Cq range, number of PRRSV RT-rtPCR reactions and number of PCV2 rtPCR reactions. 
Expected Cq Range # of Extractions 
PRRS RT-rtPCR 
Reactions/Extraction 
PCV2 rtPCR 
Reactions/Extraction 
31-32 
1 
2 
3 
10 
10 
10 
15 
15 
15 
32-33 
1 
2 
3 
10 
10 
10 
15 
15 
15 
33-34 
1 
2 
3 
10 
10 
10 
15 
15 
15 
34-35 
1 
2 
3 
10 
10 
10 
15 
15 
15 
35-36 
1 
2 
3 
10 
10 
10 
15 
15 
15 
36-37 
1 
2 
3 
10 
10 
10 
15 
15 
15 
37-38 
1 
2 
3 
10 
10 
10 
15 
15 
15 
38-39 
1 
2 
3 
10 
10 
10 
15 
15 
15 
39-40 
1 
2 
3 
10 
10 
10 
15 
15 
15 
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Figure 2.1 Boxplots representing all 270 PRRSV RT-rtPCR actual Cq values per each expected 
Cq range for each sample matrix. (A) Viral isolate, (B) lung homogenate, (C) serum, and (D) oral 
fluids. Boxplots illustrate median, 25th percentile, 75th percentile, and the mean with an X. Data 
in the plot is the actual Cq subtracted from 40, giving the inverse Cq. Significance difference 
between groups based on p-values: <0.1 = *, <0.05 = **, <0.01 = ***. 
A. B. 
C. D. 
*** *** *** *** 
*** 
*** *** ** 
*** *** *** *** 
*** * *** 
*** *** *** *** 
*** *** *** ** 
*** *** *** *** 
*** *** ** * 
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Figure 2.2 Boxplots representing all 405 PCV2 rtPCR actual Cq values per each expected Cq 
range for each sample matrix. (A) Viral isolate, (B) lung homogenate, (C) serum, and (D) oral 
fluids. Boxplots illustrate median, 25th percentile, 75th percentile, and the mean with an X. Data 
in the plot is the actual Cq subtracted from 40, giving the inverse Cq. Significance difference 
between groups based on p-values: <0.1 = *, <0.05 = **, <0.01 = ***. 
A. B. 
C. D. 
*** *** *** *** 
*** *** 
* 
*** *** *** *** 
*** *** 
*** *** *** *** 
*** * 
*** *** *** *** 
*** ** *** *** 
34 
 
 
Figure 2.3 PRRSV RT-rtPCR percent repeatability of positive actual Cq values for each expected 
Cq range at different Cq cycle cutoff values of 37 and 40 for each sample matrix. (A) Viral 
isolate, (B) lung homogenate, (C) serum, and (D) oral fluids. Data shown is represented as a 
percentage of PRRSV target detected out of 30 RT-rtPCR reactions for each expected Cq range. 
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Figure 2.4 PCV2 rtPCR percent repeatability of positive actual Cq values for each expected Cq 
range at different Cq cycle cutoff values of 35 and 40 for each sample matrix. (A) Viral isolate, 
(B) lung homogenate, (C) serum, and (D) oral fluids. Data shown is represented as a percentage 
of PCV2 target detected out of 45 rtPCR reactions for each expected Cq range. 
 
 
 
36 
 
CHAPTER 3.    REPEATABILITY OF PORCINE REPRODUCTIVE AND 
RESPIRATORY SYNDROME VIRUS OPEN READING FRAME 5 SEQUENCING AT 
DIFFERENT CONCENTRATIONS IN VARIOUS CLINICAL SAMPLE MATRICES 
 
Manuscript in preparation for submission to Journal of Veterinary Diagnostic Investigation 
 
Nicholas Streauslina, Chong Wanga, Phillip C. Gaugera, Karen M. Harmona# 
 
aDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University 
College of Veterinary Medicine, Veterinary Diagnostic Laboratory, 1850 Christensen Drives, 
Ames, Iowa 50011, United States of America, nas3@iastate.edu; kharmon@iastate.edu; 
chwang@iastate.edu 
 
#Corresponding author: Karen M. Harmon, Veterinary Diagnostic & Production Animal 
Medicine, Iowa State University, Veterinary Diagnostic Laboratory, 1850 Christensen Drive, 
Ames, IA 50011-1134. kharmon@iastate.edu 
 
 
Abstract 
Open reading frame 5 (ORF5) is an important genetic region for Porcine Reproductive 
and Respiratory Syndrome Virus (PRRSV) epidemiology and monitoring due to its genetic 
diversity. Serial dilutions using a PRRSV isolate and positive clinical samples were created to 
examine the effect of viral concentration and sample matrix on ORF5 sequencing repeatability. 
The sample matrices evaluated were serum, oral fluid, and lung homogenate selected from 
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clinical diagnostic cases submitted to the Iowa State University Veterinary Diagnostic 
Laboratory (ISU VDL). A dilution series was produced based on reverse transcription real-time 
PCR Cq values detected in the isolate and samples. Eight groups of expected Cq ranges were 
created (29-30, 30-31, 31-32, 32-33, 33-34, 34-35, 35-36, 36-37) and extracted in triplicate. Five 
ORF5 amplification PCR reactions from each extraction for a total of 120 PCR reactions were 
conducted, and PCR products were sequenced via Sanger sequencing. The results demonstrated 
the repeatability of generating full length, acceptable sequences decreased as the Cq values 
increased for all sample matrices and PRRSV isolate. The percent identity of each assembled 
contig within the dilution series was also examined. The results indicate that the number of 
ambiguous bases per sequence increases as the Cq values increase. These results demonstrate that 
repeated testing of the same sample may not result in a complete sequence regardless of the 
sample matrix if the virus concentration is low or nearing the limit of detection. 
Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the costliest 
viruses to the swine industry. In 2012, it was estimated that the virus costs United States (US) 
swine producers approximately $664 million annually (Holtkamp et al. 2013a). Monitoring the 
presence of PRRSV is standard practice for many swine producers today. PRRSV is a member of 
the Arteriviridae family (Zimmerman et al. 2012a). The PRRSV genome is approximately 15kb 
in length and consists of positive sense RNA organized into 11 open reading frames (ORFs) 
(Conzelmann et al. , Zimmerman et al. 2012a). Identification and differential classification of 
PRRSV within production systems have been common practices since the 1990’s. Restriction 
fragment length polymorphism (RFLP) patterns based on ORF5 were initially used to 
differentiate PRRS viruses (Murtaugh 2012). The ORF5 is a highly genetically variable region of 
the genome encoding the major envelope protein. Previously, RFLP patterns were used to 
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determine if a virus was a vaccine strain or a wild-type virus. However, due to the genetic 
variability of PRRSV and the ORF5 gene, RFLP patterns are no longer useful to establish 
genetic relatedness of PRRSV as viruses with the same RFLP pattern could be genetically 
unrelated (Murtaugh 2012). The industry currently uses ORF5 gene sequencing and phylogenetic 
analysis rather than RFLP patterns to determine virus relatedness. Due to the high economic 
impact of PRRSV, the repeatability and sensitivity of procedures used to sequence the ORF5 
gene to adequately monitor PRRSV epidemiological diversity need to be understood to best 
utilize the data. 
 There are several factors to consider when evaluating the usefulness of diagnostic assays, 
such as repeatability, reproducibility, sensitivity, specificity, and accuracy (Bustin et al. 2009b). 
Although these factors are important when evaluating a diagnostic test, this work specifically 
focuses on the repeatability of a PRRSV ORF5 sequencing process utilized in a diagnostic 
laboratory. Repeatability has been defined as how often the same sample will result in the same 
outcome when tested multiple times (Bustin et al. 2009b). In this work, the repeatability was 
evaluated through two outcomes. First, repeatability was determined by the frequency of 
generating acceptable sequencing data after PCR amplification and Sanger sequencing. Second, 
repeatability was determined by comparing the similarity of sequences obtained from samples 
within and between the various expected Cq ranges. 
 It is important to understand limitations of assays when used in diagnostic laboratories. 
As concentration of a PCR target in a specimen approaches the limit of detection of the assay, 
the repeatability and sensitivity of these diagnostic tests often decrease. This phenomenon is 
often observed at the Iowa State University Veterinary Diagnostic Laboratory (ISU VDL) during 
routine testing. Clients often request a retest if they receive an unexpected result; when target 
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concentrations are near the limit of detection in the specimen, the retest result may not repeat the 
original result. This can lead to assumptions that the testing laboratory made an error when in 
fact the discrepancy is a factor of the limitation of the assay. Understanding the repeatability and 
sensitivity of assays, including the ability to generate accurate ORF5 sequences, is imperative to 
diagnosticians, veterinarians, and producers who rely on accurate diagnostic results to make 
management decisions with significant economic impact. 
 The objective of this work was to evaluate the repeatability of generating acceptable 
PRRSV OFF5 sequencing data, and to evaluate the repeatability of the nucleic acid sequences 
obtained through the sequencing process by comparing the percent identity and the number of 
ambiguous bases.   
Methods  
Virus Isolate 
PRRS virus PRRSV/Ohio/67318/2016 (GenBank number MT376723) with restriction 
fragment length polymorphism (RFLP) pattern 1-7-4 was isolated from serum collected from 
adult swine in Ohio with an unknown history and submitted to the ISU VDL in 2016. The 
genome is 15,110 nucleotides and the virus is a lineage 1 PRRSV propagated on MARC145 cells 
for 2 passages. 
Clinical Sample Collection and Processing   
Clinical samples selected from routine diagnostic submissions to the ISU VDL included 
lung, serum and oral fluid that were positive for PRRSV by reverse transcription, real-time PCR 
(RT-rtPCR) conducted at the ISU VDL per standard operating procedures. Lung homogenates 
were prepared with 3 grams of tissue in 30mL of Earle’s Balanced Salt Solution (ThermoFisher 
Scientific, Waltham, MA) and placed in a stomacher (Thomas Scientific, Swedesboro, NJ) for 
120 seconds. The homogenates were centrifuged for 10 minutes at 4200 x g at 4°C and the 
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supernatant decanted into 5mL polystyrene tubes (BD Falcon, BD Biosciences, San Jose, CA). 
Blood samples received in serum separator tubes were processed via centrifugation at 1300 x g 
for 10 minutes and the serum stored in 5mL polystyrene tubes. Oral fluids submitted to the ISU 
VDL were aliquoted and stored in 5mL polystyrene tubes. Lung homogenates, sera and oral 
fluids were stored at -80°C until further use. Lung, serum and oral fluid submitted to the ISU 
VDL and RT-rtPCR negative for PRRSV were selected for diluting the positive clinical samples 
to expected Cq values. Diluent specimens were confirmed PCR negative by testing in triplicate 
and were stored at -80°C until further use. 
Experimental Design 
The PRRSV isolate and positive clinical specimens (lung homogenates, sera, oral fluids) 
were tested via RT-rtPCR to establish Cq values of the stock virus isolate and undiluted clinical 
specimens. The virus isolate was diluted in phosphate buffered saline (PBS, 1X, pH 7.2) 
(ThermoFisher) and clinical specimens were diluted in their respective RT-rtPCR negative 
matrices to an expected Cq range of 28-29. Subsequent 2-fold serial dilutions were created from 
this starting Cq range using PBS for the virus isolate or corresponding RT- rtPCR negative 
diluent lung homogenate, serum, or oral fluid for clinical specimens to create seven additional 
dilutions at expected Cq ranges 29-30, 30-31, 31-32, 32-33, 33-34, 34-35, and 35-36. The viral 
isolate and clinical specimens corresponding to their expected Cq range were extracted in 
triplicate and ORF5 amplification was performed 5 times per extract (Table 1).   
Virus Isolation 
The PRRSV/Ohio/67318/2016 was propagated in Marc-145 cells, a clone of the African 
monkey kidney cell line MA-104 (Kim et al. 1993). The cells were cultured and maintained in 
RPMI-1640 medium (ThermoFisher) supplemented with 10% fetal bovine serum (Atlas 
Biologics, Fort Collins, CO), 2mM L-glutamine, 0.05 mg/mL gentamicin, 10 units/mL penicillin, 
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10 µg/mL streptomycin, and 0.25 µg/mL amphotericin B (Sigma-Aldrich, St. Louis, MO). Cells 
were grown at 37°C in 5% CO2 until confluent. Virus titrations were performed in a 96-well 
plate of Marc-145 cells by inoculating 10-fold serial dilutions of the virus (100µL per well) in 
triplicate per dilution. After four days incubation, virus-specific cytopathic effect was recorded, 
and the plates were subjected to immunofluorescence staining with PRRSV-specific monoclonal 
antibodies conjugated to fluorescein isothiocyanate.  
Nucleic Acid Extraction 
Nucleic acids were extracted from expected Cq ranges described in Table 1 that were 
generated from the PRRSV isolate and RT-rtPCR positive lung homogenate, serum and oral 
fluid using a KingFisher® Flex (ThermoFisher) automated magnetic particle processor system 
and a commercial extraction kit MagMAX™ Pathogen RNA/DNA Kit (ThermoFisher) 
according to manufacture specifications. Viral isolates, lung homogenates and sera were 
extracted using “standard” chemistry, whereas the oral fluids were extracted using the “high 
volume” chemistry. The “standard” lysis extraction contained: 50µL of sample, 65µL of 
lysis/binding solution concentrate, 65µL of 100% isopropanol, 1µL of carrier RNA (1 µg/µL), 
and 2µL of Xeno™ RNA (10,000 copies/µL). The standard wash steps used 150µL of wash 
buffer 1 and wash buffer 2. The viral isolate and clinical specimens were extracted in triplicate in 
a 96-well format. Nucleic acid extracts were not frozen prior to PCR set up to eliminate possible 
effects from freeze/thaw cycles. Extracted nucleic acids were stored at 4°C and immediately used 
in their PCR and RT-rtPCR reactions. 
RT-qPCR, ORF5 PCR, and Sequencing 
PRRSV RT-qPCR 
The PRRSV RT-rtPCR was performed using the 10X PRRSV Primer Probe Mix V2 from 
the VetMAX™ PRRSV NA and EU kit (ThermoFisher). The assay was modified from the 
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original kit to use TaqMan Fast Virus 1-Step Master Mix (4X) at a higher level than that 
recommended in the original product insert, and with the addition of Amplitaq 360 DNA 
Polymerase. Each reaction consisted of 6.5µL of TaqMan Fast Virus 1-Step Master Mix (4X), 
0.8µL Amplitaq 360 DNA Polymerase (5U/µL), 2.7µL of nuclease-free water, 2.0µL of the 10X 
PRRSV Primer Probe Mix V2, and 8.0µL of nucleic acid template. Each plate included one of 
each positive extraction control, positive amplification control, negative extraction control, and 
negative amplification control. The assay was conducted on the ABI-7500 Fast system 
(ThermoFisher), using the 7500 Fast System SDS Software Version 1.4.0.27. The ABI-7500 was 
set to run in fast mode, with cycling conditions: 5 minutes at 50°C; 20 seconds at 95°C; 40 
cycles of 95°C for 3 seconds and 60°C for 30 seconds. 
ORF5 Amplification and Sequencing 
ORF5 was amplified using a qScript™ XLT One-Step RT-qPCR ToughMix® 
(QuantaBio) master mix. The primers consisted of the forward primer, P5F2 (5’-
AAGGTGGTATTTGGCAATGTGTC-3’), and the reverse primer, P5R2 (5’-
GAGGTGATGAATTTCCAGGTTTCTA-3’). Each amplification reaction consisted of 13µl of 
qScript XLT One-Step RT-qPCR ToughMix (2X), 1μl of qScript XLT reverse transcriptase 
(25X), 0.4μl of each primer (20μM), 6.7μl of nuclease-free water, and 4μl nucleic acid template. 
The assay was run on the Applied Biosystems 2720 thermal cycler. The cycling conditions were 
as follows: 48°C for 20 min; 94°C for 3 min; 45 cycles at 94°C for 30 s, 50°C for 50 s, and 68°C 
for 50 s; and 68°C for 7 min. All amplicons were submitted to the Iowa State University DNA 
Facility for Sanger sequencing. 
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Data Analysis 
 Sequencing Analysis 
Sequencing data was analyzed using SeqMan Pro Version 15.0.1.1 (DNASTAR, Inc.). 
Sequence contigs were assembled and trimmed to include only the ORF5 sequence with a length 
of 603 base pairs. Sequence data which could not be assembled or did not have double coverage 
were considered not acceptable or negative. Ambiguous nucleotide bases were determined by the 
sequence analysis program. Acceptable sequences were aligned with a ClustalW algorithm in 
MegAlign Version 15.0.1.1 (DNASTAR, Inc.).  
Statistical Analysis 
Data was analyzed using Microsoft Excel. Line charts and boxplots were made in Excel 
from data generated in MegAlign. 
Results 
Repeatability of Acceptable PRRSV Sequencing Data 
PRRSV ORF5 amplification was performed 15 times from each dilution, with 3 separate 
extractions and 5 amplifications from each extraction, as illustrated in Table 1. Each extract was 
tested via RT-rtPCR before ORF5 amplification to verify the actual Cq values of the expected Cq 
ranges (Table 1). Sequencing was considered positive if the assembled contig had double 
coverage over the entire 603 base length of ORF5. The results of all sample matrices across all 
expected Cq ranges is shown in Figure 1. The isolate was the most repeatable matrix, with 3 of 
the expected Cq ranges, 29-30, 30-31, and 32-33, demonstrating 100% (15/15) success 
generating acceptable sequences, and total of 85 out of the 120 (70.8%) possible acceptable 
sequences across all the expected Cq ranges. Oral fluid was the next most repeatable with two 
expected Cq ranges having 100% (15/15) success, and 63 (52.5%) total acceptable sequences. 
Neither the serum nor lung had any group with 100% repeatability. The lung homogenate had a 
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total of 57 (47.5%) acceptable sequences, while the serum had the lowest amount of acceptable 
sequences with only 45 (37.5%). With few exceptions, the percent repeatability declined with 
increasing Cq for all sample types. All the of the matrices, except for the isolate, had 0% 
repeatability at the highest (35-36) expected Cq range. At the expected Cq range of 32-33, all the 
matrices, expect the isolate, had lower than 50% repeatability, with only one acceptable sequence 
generated from the serum. 
Repeatability of PRRSV Nucleotide Sequences 
In order to examine whether the increasing expected Cq values had any effect on the 
repeatability of the nucleotide bases within the ORF5 sequence, the acceptable sequences were 
compared within each sample matrix and expected Cq range. Boxplots were made from the 
percent identity values for each of the expected Cq ranges and are shown in Figure 2. The final 
sequences were processed to contain only the 603 base pairs of ORF5, and ambiguous bases 
were left unchanged and remained as the software assigned the bases. For all the of the sample 
matrices, the general trend of the data demonstrates both the range and the interquartile range of 
percent identities increases as the expected Cq values increase. All the sample matrices, 
excluding the lung homogenate, had a percent identity of 98-100% for the 28-29 expected Cq 
range. All the sample matrices eventually fall below 90% percent identity with the lung 
homogenate demonstrating the lowest identity at 84% in the 33-34 range.  
The number of ambiguous bases from each of the assembled sequences was totaled for 
each of the expected Cq ranges for each of the sample matrices. The total number of ambiguous 
bases was divided by the total number of acceptable sequences within that expected Cq range. 
This defined the ratio of ambiguous bases per sequence and depicted in Figure 3. The number of 
ambiguous bases per sequence increases for all the sample matrices as the Cq value increases. 
The observed trend is expected based on the data from Figure 2, as the number of ambiguous 
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bases increases, the lower the percent identity. All the sample matrices start with a ratio of less 
than 10 ambiguous bases per sequence. The ratio continued to rise as the expected Cq values 
increased with a ratio of 70 the highest number of ambiguous bases per sequence, observed in 
the serum matrix at the expected Cq range of 32-33. The additional sample matrices 
demonstrated much lower ratios of ambiguous bases per sequence. At the same expected Cq 
range, the isolate, lung homogenate, and oral fluid demonstrated ratios of approximately 30, 35, 
and 20, respectively. The number of ambiguous bases per sequence increases in the higher 
expected Cq ranges as the data becomes influenced by the low number of acceptable sequences 
that were available to analyze; this is observed in the isolate at the 34-35 expected Cq range, the 
lung homogenate at the 33-34 range, and the oral fluid at the 32-33 range. 
Discussion 
This work utilized multiple dilutions of various RT-rtPCR positive clinical specimen 
types to examine the effect of viral concentration on the success of diagnostic ORF5 sequencing. 
The PRRSV RT-rtPCR positive clinical samples were diluted with their respective RT-rtPCR 
negative sample matrix from ISU VDL submissions as opposed to spiking the samples with virus 
isolates to more accurately represent outcomes expected from actual diagnostic specimens 
submitted from field cases. The range representing Cq values from 28-36 were chosen to 
represent low virus concentrations that are often detected in ISU VDL submissions and 
considered of questionable repeatability with RT-rtPCR as well as sequencing. Two-fold serial 
dilutions were also used in contrast to ten-fold dilutions to more fully evaluate a breadth of Cq 
ranges that could be selected for sequencing at a diagnostic laboratory as each two-fold dilution 
should theoretically yield a Cq increase of 1.0. Collectively, these data suggest that PRRSV 
ORF5 sequencing repeatability decreased or were unable to generate an acceptable sequence at 
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Cq values of 33 or higher. These results are consistent with observations in diagnostic cases at 
the ISU VDL that request PRRSV ORF5 sequencing.  
It is imperative that the results of diagnostic assays for agents such as PRRSV be 
analyzed, reported, and interpreted correctly due to the potential economic impact of subsequent 
management decisions(Holtkamp et al. 2013b). When producers and veterinarians receive 
positive RT-rtPCR results, it is common to request sequencing to determine if the virus that was 
detected is derived from a modified-live PRRSV vaccine or from a wild-type strain, as well as 
for epidemiological tracking of the virus. For swine production operations, monitoring and 
tracking the viral history of the production system is essential for making management decisions 
to mitigate production losses and protect the health of the herd.  These data indicate that ORF5 
sequencing may vary in success when virus concentrations approach elevated Cq values 
suggesting gene sequencing also has a limit of detection although the sample is considered 
positive for the virus. Understanding at what RT-rtPCR Cq values sequencing success may 
significantly be decreased or quality of sequence negatively impacted can provide guidelines for 
client follow up to a positive PCR result and suggests caution when evaluating sequence 
comparisons through phylogenetic analysis.  A real-time PCR positive result on a sample that 
cannot be sequenced may seem inconsistent to clients, causing doubt in the reliability of the 
results. The work presented here elucidates the potential frequency of these occurrences at 
different Cq ranges for PRRSV ORF5 sequencing. Although this work has shown that 
sequencing accuracy decreases with lower concentrations of virus, the accuracy may be 
improved with diligent data analysis and editing performed by a trained analyst. When 
interpreting any diagnostic result, additional testing and evaluation of animal health status and 
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clinical history can provide additional useful information for making proper management 
decisions for protecting and maintaining herd health status. 
A limitation of the methodology presented here was that it cannot directly compare 
whether the sample matrix affects the success of the sequencing results, since each of the clinical 
samples most likely contained a different strain, and sequence, of PRRSV. Due to genetic 
variation in the viruses, we cannot conclude that the results of the ORF5 sequencing observed 
between the different sample matrices could be attributed to the specimen matrix. The study was 
designed to mimic actual diagnostic conditions to the extent possible. Samples were selected 
from different submissions to the ISU VDL and represent various production systems, which 
adds another variable that must be considered when comparing the results between sample 
matrices. In addition, sample collection, handling and shipping can vary between submissions 
and these factors could also affect the quality of the sample and ultimately the diagnostic results. 
In future work it would be worth investigating whether different sample matrices impact the 
success of sequencing results using spiked viral samples in a more controlled experimental 
design, as opposed to diagnostic conditions, although inoculating samples with a virus may not 
represent the true biological nature of samples submitted to a diagnostic laboratory. There are 
many aspects to consider in different sample matrices that could impact the repeatability, such as 
the amount of host nucleic acid, the various PCR inhibitors in different sample types, and the 
quality of sample types generally received (Rossen et al. , Al-Soud, Jönsson Lj Fau - Râdström 
and Râdström). In diagnostic cases submitted to the ISU VDL, sample quality can vary 
substantially within the same sample matrix.  Perhaps the specimen type that is often considered 
to present the most variability in quality is oral fluids. Clinical oral fluid samples received by the 
ISU VDL can vary greatly in the amount of particulate matter and viscosity. 
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In practice, in the ISU VDL, sequencing is most often requested as a follow up to a 
positive real-time PCR result, after the samples have been placed into storage at -80°C. In some 
instances, additional testing may have been requested on the samples prior to sequencing, 
causing samples to incur multiple freeze-thaw cycles. In this study, freeze-thaw cycles were 
avoided as each target dilution was only frozen once before extraction but evaluating the effect 
of freeze-thaw would be warranted in a future study. It has been shown that multiple freeze-thaw 
cycles can impact detection in Influenza A Virus PCR positive samples (Granados et al. 2017). 
However, that study evaluated only detection of the virus and not genetic sequencing.  
Diagnostic sequencing is an important tool for diagnosticians, producers, veterinarians, 
and epidemiologists. Monitoring herd health and circulation of existing or new viruses is 
frequently based on sequence data generated by a diagnostic laboratory. Sequence data can also 
be used for monitoring new and emerging viral quasi-species, and the spread of new virus. With 
this work, we have investigated the repeatability and sensitivity of diagnostic sequencing. The 
data presented here should be useful for better understanding the limitations and use of this 
diagnostic tool. 
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Figures and Tables 
Table 3.1 Experimental design depicting the target Cq ranges, number of extractions per target Cq 
range, RT-rtPCR Cq results for each extract, and number of sequencing reactions. 
Sample 
ID 
Expected 
Cq 
Extraction 
# 
Isolate Lung 
Oral 
Fluid 
Serum 
Sequence 
reaction # 
1 28-29 
1 
2 
3 
28.4 
28.5 
28.8 
28.0 
28.2 
28.3 
28.4 
28.2 
28.3 
28.4 
28.5 
28.3 
5 
5 
5 
2 29-30 
1 
2 
3 
29.5 
29.5 
29.7 
29.4 
29.6 
29.5 
29.5 
29.6 
29.2 
29.7 
29.7 
29.9 
5 
5 
5 
3 30-31 
1 
2 
3 
30.4 
30.8 
31.0 
30.4 
30.7 
30.7 
30.3 
30.3 
30.2 
30.8 
30.7 
30.4 
5 
5 
5 
4 31-32 
1 
2 
3 
31.4 
31.9 
31.6 
31.2 
31.6 
31.7 
31.2 
31.0 
31.2 
31.9 
32.2 
31.9 
5 
5 
5 
5 32-33 
1 
2 
3 
32.3 
32.9 
32.3 
32.3 
32.0 
32.0 
32.0 
32.5 
32.2 
32.6 
32.4 
32.8 
5 
5 
5 
6 33-34 
1 
2 
3 
33.6 
33.6 
33.5 
33.3 
33.1 
33.0 
33.1 
33.2 
33.8 
34.1 
33.5 
33.4 
5 
5 
5 
7 34-35 
1 
2 
3 
34.4 
34.2 
34.4 
34.2 
33.9 
33.9 
35.0 
35.8 
34.8 
35.0 
34.8 
34.6 
5 
5 
5 
8 35-36 
1 
2 
3 
36.4 
35.3 
37.1 
35.3 
36.6 
34.7 
35.2 
35.7 
35.8 
35.6 
34.6 
36.2 
5 
5 
5 
Cq = Quantification cycle 
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Figure 3.1. Percent repeatability of generating an acceptable PRRSV ORF5 sequence from each 
sample matrix. The percent of acceptable PRRSV ORF5 sequences is based on the results of 15 
sequencing reactions for the PRRSV isolate and sample types. Results that provided acceptable 
sequencing data were considered positive. 
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Figure 3.2. Percent nucleotide identity of the acceptable PRRSV ORF5 sequences within each Cq 
range and sample matrix. Data is demonstrated with boxplots representing the mean, 25th and 
75th quartile for (A) PRRSV isolate, (B) lung homogenate, (C) oral fluid, (D) serum. 
A
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B
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C
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D
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Figure 3.3. Ratio of ambiguous bases per sequence for each sample matrix. Ratio of ambiguous 
bases per sequence determined by DNAStar and detected in the PRRSV ORF5 sequence from 
the PRRSV isolate, lung homogenate, oral fluid, and serum. The ratio is defined as the sum of 
the total number of ambiguous bases divided by the number of acceptable PRRSV ORF5 
sequences in the respective expected Cq range for each sample type. Unacceptable sequences 
were not included in the analysis. 
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CHAPTER 4.    GENERAL CONCLUSIONS 
The main objective of the work in this thesis was to determine and examine the 
repeatability of two common molecular diagnostic assays, real-time PCR and Sanger sequencing. 
First, real-time PCR assays for PRRSV and PCV2 were examined. These are both common and 
costly viruses to the swine industry (Holtkamp et al. 2013b, Gillespie et al. 2009a). This made 
evaluating these particular assays an ideal choice to use in this work. Our hypothesis for the real-
time PCR repeatability was, as the viral load of the sample decreases the repeatability of the 
assay decreases. This hypothesis was based on observations made at the ISU VDL during routine 
testing. The work in this thesis was designed to provide data to support these observations. The 
results reinforce this hypothesis. Along with providing support for the hypothesis, the data shows 
that the variance of the results increases as the viral load decreases. Next, the repeatability of the 
sequencing assay was evaluated. Our hypothesis was similar to the hypothesis for the real-time 
PCRs; as the viral load decreases, the number of successful sequencing results would also 
decrease. Once again, this was based on observations made at the ISU VDL. It is common for 
sequencing assays to fail on samples with elevated Cq values. The results presented in Chapter 3 
support this hypothesis, and the observations made at the ISU VDL. 
 There are many other research questions outside the scope of this thesis to investigate in 
future work. The work presented here was designed to examine the repeatability of actual 
clinical samples for both the real-time assays and the sequencing assay rather than 
experimentally created samples. This was to provide a more accurate look at clinical samples 
that VDLs would receive as regular submissions. Due to this decision, the effect of sample 
matrix cannot fairly be compared between each type. This is because the viruses that exist in 
each of the sample matrices chosen is different and represent different nucleotide sequences with 
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variations in complementarity to the primers and probes in their respective real-time PCRs and 
sequencing amplification PCR. The samples used in this work were received from different 
producers from around the county at different times. Repeating the methodology presented in 
Chapter 2 and Chapter 3 with sample matrices spiked with the same virus could provide valuable 
insight of the effect of sample matrix on repeatability for both real-time PCR assays and 
sequencing assays. This could also be investigated with an animal infection study using the same 
virus and collecting different sample types establishing specimens of known status. This would 
be a more expensive approach but would provide a more accurate evaluation into how the 
sample matrix affects repeatability.  
 There are other factors which still need to be investigated to fully understand the 
repeatability of molecular diagnostic assays. Factors beyond the assay itself could influence 
repeatability. Often when retests are completed at VDLs, the samples have experienced one or 
several freeze-thaw cycles. This could have an influence on the results of the retest often 
presumed a negative impact. The methodology described here could be applied to a freeze-thaw 
study, with different successive number of freeze-thaw cycles and at different lengths of the 
cycles. Previous work examining the effect of freeze-thaw cycles has been done with Influenza 
using copies/µl of viral RNA in nasopharyngeal swabs (Granados et al. 2017). It would be 
worthwhile to examine the effect freeze-thaw has on high Cq values and the repeatability of the 
assay, and whether sample matrix has an effect. This could also be applied to the sequencing 
assay, to evaluate the effect on the number of successful sequencing reactions.  
 The work presented in this thesis will provide diagnosticians, veterinarians, and 
producers with valuable insight into the repeatability of these essential assays. While these 
assays are incredibly powerful tools, it is important to understand their limitations, too. When 
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assays have high Cq values and results do not repeat, it is important to use other diagnostic assays 
to gain a more complete picture of what is happening with an animal or herd. Or, it may require a 
re-sample or new sample submission to the VDL to confirm the status of the population rather 
than rely on repeated testing of the same sample considering disease status changes with time. 
The data presented here can give clients a better understanding as to why late Cq results do not 
always repeat. Knowing this information is essential to giving clients accurate and trustworthy 
results. 
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